MIRUM PHARMACEUTICALS INC

Insider buy at Mirum Pharmaceuticals signals confidence amid a 104 % rally; 159k shares purchased by owner Heron Patrick J at $99.27, boosting optimism for liver‑disease pipeline.

Mirum insider Saira Saira’s buy‑sell‑option trades reveal a risk‑managed strategy that signals confidence in Mirum’s growth, while her pattern of buying low and selling high underscores a bullish outlook on the company’s prospects.